Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone (Q57601982)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Fatigue in progressive multiple sclerosis is associated with low levels of dehydroepiandrosterone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Mar Tintoré

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Xavier Montalban

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Nieves Téllez

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Manuel Comabella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Luís Brieva

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Carlos Nos

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Eva Julià

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 August 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

Multiple Sclerosis Journal

28 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

487-494

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

Fatigue associated with multiple sclerosis: diagnosis, impact and management

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Fatigue in multiple sclerosis is associated with abnormal cortical activation to voluntary movement--EEG evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Functional magnetic resonance imaging correlates of fatigue in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Effects of exercise on muscle activation and metabolism in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Chronic fatigue syndrome: new insights and old ignorance

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Fatigue and proinflammatory cytokine activity in breast cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Replacement therapy in Addison's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Immunologic abnormalities associated with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Fatigue is not associated with raised inflammatory markers in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Cytokine mRNA expression in patients with multiple sclerosis and fatigue

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Defining the clinical course of multiple sclerosis: Results of an international survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

An Inventory for Measuring Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS?

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Differences in adrenal steroid profile in chronic fatigue syndrome, in depression and in health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

An open study of dehydroepiandrosterone in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Dissociation of Cortisol and Adrenal Androgen Secretion in Patients with Secondary Adrenal Insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Dehydroepiandrosterone therapy ameliorates experimental autoimmune myasthenia gravis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Protection against inflammatory neurodegeneration and glial cell death by 7beta-hydroxy epiandrosterone, a novel neurosteroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Side effect profile of interferon beta-1b in MS: results of an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Pharmacokinetics of dehydroepiandrosterone and its metabolites after long-term daily oral administration to healthy young men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

Primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F135248505MS1322OA

10.1191/135248505MS1322OA

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16900763%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference